NCT01585259View on ClinicalTrials.gov

Anfibatide Phase Ib-IIa Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

July 31, 2015

Conditions
Non-ST Segment Elevation Myocardial Infarction
Interventions
DRUG

Anfibatide

Snake venom

DRUG

Placebo

Saline

Trial Locations (1)

100000

Peking University First hospiatl, Beijing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY

NCT01585259 - Anfibatide Phase Ib-IIa Clinical Trial | Biotech Hunter | Biotech Hunter